94 related articles for article (PubMed ID: 16455125)
1. An intact sequence-specific DNA-binding domain is required for human cytomegalovirus-mediated sequestration of p53 and may promote in vivo binding to the viral genome during infection.
Rosenke K; Samuel MA; McDowell ET; Toerne MA; Fortunato EA
Virology; 2006 Apr; 348(1):19-34. PubMed ID: 16455125
[TBL] [Abstract][Full Text] [Related]
2. Potential role for p53 in the permissive life cycle of human cytomegalovirus.
Casavant NC; Luo MH; Rosenke K; Winegardner T; Zurawska A; Fortunato EA
J Virol; 2006 Sep; 80(17):8390-401. PubMed ID: 16912290
[TBL] [Abstract][Full Text] [Related]
3. p53 and RPA are sequestered in viral replication centers in the nuclei of cells infected with human cytomegalovirus.
Fortunato EA; Spector DH
J Virol; 1998 Mar; 72(3):2033-9. PubMed ID: 9499057
[TBL] [Abstract][Full Text] [Related]
4. Interaction of human polyomavirus BK with the tumor-suppressor protein p53.
Shivakumar CV; Das GC
Oncogene; 1996 Jul; 13(2):323-32. PubMed ID: 8710371
[TBL] [Abstract][Full Text] [Related]
5. Human cytomegalovirus IE1-72 activates ataxia telangiectasia mutated kinase and a p53/p21-mediated growth arrest response.
Castillo JP; Frame FM; Rogoff HA; Pickering MT; Yurochko AD; Kowalik TF
J Virol; 2005 Sep; 79(17):11467-75. PubMed ID: 16103197
[TBL] [Abstract][Full Text] [Related]
6. Human cytomegalovirus labeled with green fluorescent protein for live analysis of intracellular particle movements.
Sampaio KL; Cavignac Y; Stierhof YD; Sinzger C
J Virol; 2005 Mar; 79(5):2754-67. PubMed ID: 15708994
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of p53 transcriptional activity by human cytomegalovirus UL44.
Kwon Y; Kim MN; Young Choi E; Heon Kim J; Hwang ES; Cha CY
Microbiol Immunol; 2012 May; 56(5):324-31. PubMed ID: 22376288
[TBL] [Abstract][Full Text] [Related]
8. The human cytomegalovirus IE2 86 kDa protein elevates p53 levels and transactivates the p53 promoter in human fibroblasts.
Muganda P; Carrasco R; Qian Q
Cell Mol Biol (Noisy-le-grand); 1998 Mar; 44(2):321-31. PubMed ID: 9593583
[TBL] [Abstract][Full Text] [Related]
9. Human cytomegalovirus pUL29/28 and pUL38 repression of p53-regulated p21CIP1 and caspase 1 promoters during infection.
Savaryn JP; Reitsma JM; Bigley TM; Halligan BD; Qian Z; Yu D; Terhune SS
J Virol; 2013 Mar; 87(5):2463-74. PubMed ID: 23236067
[TBL] [Abstract][Full Text] [Related]
10. HCMV IE2-mediated inhibition of HAT activity downregulates p53 function.
Hsu CH; Chang MD; Tai KY; Yang YT; Wang PS; Chen CJ; Wang YH; Lee SC; Wu CW; Juan LJ
EMBO J; 2004 Jun; 23(11):2269-80. PubMed ID: 15141169
[TBL] [Abstract][Full Text] [Related]
11. Real-Time Visualization and Quantification of Human Cytomegalovirus Replication in Living Cells Using the ANCHOR DNA Labeling Technology.
Mariamé B; Kappler-Gratias S; Kappler M; Balor S; Gallardo F; Bystricky K
J Virol; 2018 Sep; 92(18):. PubMed ID: 29950406
[TBL] [Abstract][Full Text] [Related]
12. Intracellular localization and DNA-binding activity of a class of viral early phosphoproteins in human fibroblasts infected with human cytomegalovirus (Towne strain).
Iwayama S; Yamamoto T; Furuya T; Kobayashi R; Ikuta K; Hirai K
J Gen Virol; 1994 Dec; 75 ( Pt 12)():3309-18. PubMed ID: 7996125
[TBL] [Abstract][Full Text] [Related]
13. Human cytomegalovirus elevates levels of the cellular protein p53 in infected fibroblasts.
Muganda P; Mendoza O; Hernandez J; Qian Q
J Virol; 1994 Dec; 68(12):8028-34. PubMed ID: 7966592
[TBL] [Abstract][Full Text] [Related]
14. Cytoplasmic sequestration of p53 in cytomegalovirus-infected human endothelial cells.
Kovacs A; Weber ML; Burns LJ; Jacob HS; Vercellotti GM
Am J Pathol; 1996 Nov; 149(5):1531-9. PubMed ID: 8909243
[TBL] [Abstract][Full Text] [Related]
15. Identification of human cytomegalovirus target sequences in the human immunodeficiency virus long terminal repeat. Potential role of IE2-86 binding to sequences between -120 and -20 in promoter transactivation.
Yurochko AD; Huong SM; Huang ES
J Hum Virol; 1999; 2(2):81-90. PubMed ID: 10225210
[TBL] [Abstract][Full Text] [Related]
16. Stabilization of p53 in human cytomegalovirus-initiated cells is associated with sequestration of HDM2 and decreased p53 ubiquitination.
Chen Z; Knutson E; Wang S; Martinez LA; Albrecht T
J Biol Chem; 2007 Oct; 282(40):29284-95. PubMed ID: 17698841
[TBL] [Abstract][Full Text] [Related]
17. The expression of p16INK4a tumor suppressor is upregulated by human cytomegalovirus infection and required for optimal viral replication.
Zannetti C; Mondini M; De Andrea M; Caposio P; Hara E; Peters G; Gribaudo G; Gariglio M; Landolfo S
Virology; 2006 May; 349(1):79-86. PubMed ID: 16504234
[TBL] [Abstract][Full Text] [Related]
18. Human cytomegalovirus infection decreases expression of thrombospondin-1 independent of the tumor suppressor protein p53.
Cinatl J; Kotchetkov R; Scholz M; Cinatl J; Vogel JU; Driever PH; Doerr HW
Am J Pathol; 1999 Jul; 155(1):285-92. PubMed ID: 10393860
[TBL] [Abstract][Full Text] [Related]
19. In GFP with high risk HPV-18E6 fusion protein expressed 293T and MCF-7 cells, the endogenous wild-type p53 could be transiently phosphorylated at multiple sites.
Sun L; Zhang G; Li Z; Song T; Huang C; Si L
J Exp Clin Cancer Res; 2008 Sep; 27(1):35. PubMed ID: 18778462
[TBL] [Abstract][Full Text] [Related]
20. Wild-type p53 transactivates the KILLER/DR5 gene through an intronic sequence-specific DNA-binding site.
Takimoto R; El-Deiry WS
Oncogene; 2000 Mar; 19(14):1735-43. PubMed ID: 10777207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
